dose modification rationale in advanced pancreatic cancer
Published 8 years ago • 271 plays • Length 9:53Download video MP4
Download video MP3
Similar videos
-
7:14
metastatic pancreatic cancer: dosing strategies in the frontline setting
-
9:02
adjuvant therapy in locally advanced pancreatic cancer
-
38:24
current and future directions in metastatic pancreatic cancer
-
6:14
precision oncology in advanced pancreatic cancer
-
7:26
treatment for locally advanced pancreatic cancer
-
9:08
folfirinox in metastatic pancreatic cancer
-
1:05
dr. o’hara on rationale for apx005m/chemotherapy and nivolumab in pancreatic cancer
-
1:48
dr. chung on sequencing chemotherapy regimens in metastatic pancreatic cancer
-
0:39
early warning signs of pancreatic cancer: don't ignore these symptoms | dr praveen kammar
-
1:26
dr. philip on folfirinox in locally advanced pancreatic cancer
-
5:28
pegph20 in advanced pancreatic cancer
-
2:14
dr. o’reilly on agents in development in advanced pancreatic cancer
-
5:03
sequencing decisions in advanced pancreatic cancer
-
7:59
advanced pancreatic cancer: options in the adjuvant setting
-
6:50
advanced pancreatic cancer patients shrank tumor with high dose vitamin c
-
4:22
mm-398 for second-line therapy in advanced pancreatic cancer
-
8:38
modifying chemotherapy regimens in pancreas cancer
-
7:27
frontline decisions in metastatic pancreatic cancer
-
0:58
considerable improvement for pancreatic cancer.